ClearBridge Investments’s Endocyte, Inc. Common Stock ECYT Stock Holding History

ClearBridge Investments’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-891	Closed	-$16K	–	1194
2018 Q3	$16K	Hold	891	–	–	﹤0.01%	1029
2018 Q2	$12K	Sell	891 -1,234	-58%	-$14.6K	﹤0.01%	1016
2018 Q1	$19K	Buy	+2,125	New	+$11.7K	﹤0.01%	984

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

ClearBridge Investments's ECYT Position: Q4 2018 in Review

ClearBridge Investments sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 891 shares — an estimated $16K sold.

ClearBridge Investments first reported a position in ECYT in Q1 2018 and held it in 3 quarters. The position peaked at $19K in Q1 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

ClearBridge Investments reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
ClearBridge Investments sold 891 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $16K.
ClearBridge Investments first reported a position in Endocyte, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
ClearBridge Investments's Endocyte, Inc. Common Stock position peaked at $19K in Q1 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on ClearBridge Investments's 13F filing for Q4 2018, filed 14 Feb 2019.